Recombinant antibody production involves the use of recombinant DNA technology to produce an antibody. In this blog post, you will learn all about the process of recombinant antibody production ...
Liraglutide is under clinical development by Novo Nordisk and currently in Phase III for Obesity. According to GlobalData, Phase III drugs for Obesity have a 44% phase transition success rate (PTSR) ...
Liraglutide is under development for the treatment of obesity, ileal pouch-anal anastomosis and Alzheimer's disease. It was also under development for non-alcoholic steatohepatitis, psoriatic ...
DNA (deoxyribonucleic acid) is the nucleic acid polymer that forms the genetic code for a cell or virus. Most DNA molecules consist of two polymers (double-stranded) of four nucleotides that each ...
A NASA spacecraft has made history by surviving its closest-ever approach to the Sun during the Parker Solar Probe mission, a project over six years in the making. The spacecraft was out of ...
ImmunityBio, Inc. (NASDAQ:IBRX – Get Free Report) was down 5.6% during mid-day trading on Tuesday . The stock traded as low as $2.51 and last traded at $2.53. Approximately 3,579,558 shares were ...